FDA Approves At-Home Version of Lasix for Heart Failure Care

The FDA has approved Lasix ONYU, an at-home version of the heart failure drug furosemide, streamlining treatment and improving accessibility for millions of Americans managing hypervolemia and edema.

• The Food and Drug Administration approved Lasix ONYU on October 10, 2025, providing a new at-home treatment option for patients with heart failure requiring furosemide.
• Lasix ONYU is designed to alleviate symptoms of hypervolemia and edema by enabling patients to self-administer furosemide via a drug-device combination in the comfort of their homes.
• This innovative approach aims to enhance patient engagement and reduce the burden on the health system, offering a practical solution for managing chronic heart failure conditions.